TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Short Index of Problems (SIP)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in Ability to Regulate Emotions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in Ability to Regulate Attention
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Behavioral Dysregulation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Child Initiated Pretend Play Assessment (ChIPPA-2)
Endpoint domain: Life impact
Endpoint subdomain: Playfulness
Primary endpoint: Pretend Play Enjoyment-Developmental Checklist (PPE-DC)
Endpoint domain: Life impact
Endpoint subdomain: Playfulness
Primary endpoint: Percentage of complete follow up
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Impact of fibromyalgia on daily life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Geometric mean concentration (GMC) of C. difficile toxin A- and toxin B-specific neutralizing antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from baseline in Kansas City Cardiomyopathy Questionnaire (KCCQ-23 CSS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change from baseline in peak oxygen consumption (pVO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Detectable HIV Viral Load
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with Valvular Heart Disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of participants with Left Ventricular Systolic Dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Diagnostic accuracy in identifying heart valve disease or left ventricular systolic dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Decline in Verbal Memory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of Participants With Vital Signs Meeting Pre-Defined Criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gamma camera-based whole-body [99mTc]Tc-BQ0413 uptake value (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SPECT-based [99mTc]Tc-BQ0413 value in tumor lesions (counts)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Occurrence of AEs (including Injection site reactions) and SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Any grade peripheral sensory neuropathy
Endpoint domain: Adverse events/effects
Primary endpoint: Informed decision-making regarding parenteral nutrition
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: rate of persistent parasympathetic modulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of wild-type cardiac amyloidosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: C-reactive protein to serum albumin ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: back to school readiness
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Mean depth of skin wrinkles (mm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Melanin quantity (arbitrary unit from 0.1-1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Hemoglobin quantity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Safety and tolerability of SC262
Endpoint domain: Adverse events/effects
Primary endpoint: Antigen specific T cell responses in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Antigen specific T cell responses in bronchoalveolar lavage (BAL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Any grade 3, 4, or 5 adverse events related to study vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement in Visual Clarity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in Eye Dryness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in Symptoms of Inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in Sensitivity to Blue Light
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiac adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: AUC0 to Day 271
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modifications in leaks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Spontaneous Discharge
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Composite of lead dislodgement, frozen shoulder, upper arm venous thrombosis, clinically significant hematoma formation, and infection
Endpoint domain: Adverse events/effects
Primary endpoint: WaLIDD score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Premenstrual Syndrome Impact Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cigarette Dependency scale (CDS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motivation and Attitude towards changing Health (MATCH)
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Mass balance recovery of total radioactivity (TR) in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mass balance recovery of total radioactivity (TR) in faeces
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement of appropriate PK parameters of parent ANG-3777 in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Burden of atopic diseases
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Effectiveness of allergen immunotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Direct and indirect costs related to atopic diseases
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean relative reduction in liver fat content (LFC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of participants who discontinued study intervention due to an AE
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage change from baseline of ALT peak level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: The number of needle insertion attempts
Endpoint domain: Adverse events/effects
Primary endpoint: 5 Dimensions itch scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: prostaglandin E2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ventilation-free days (VFD) at 28-days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Frequency and severity of TEAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Wound surface and debris
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Incidence of abnormal physical exam findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of abnormal serum chemistries and hematology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of abnormal vital signs (temperature)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of abnormal vital signs (blood pressure)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of abnormal vital signs (heart rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skin tape stripping
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Time to remove the contraceptive implant device
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Length of incision used for the removal of the single rod contraceptive implant device
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Self-Determined Scale for Emotional Regulation - Revised (SDSE-RS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Feasibility metrics (recruitment, retention/follow up)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Ultrasound parameter score total
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in gut Metagenome Species Pangenome (MSP) richness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients satisfying ASAS 20 improvement criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of microorganisms in vaginal discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Severity of Treatment-Emergent Serious Adverse Events (TESAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of trial stopping rule event
Endpoint domain: Adverse events/effects
Primary endpoint: Source Localization of Fentanyl EEG Signature
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean percent change from baseline in Serum Concentrations of Alkaline Phosphatase (ALP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Minutes in upright position per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of times temperature exceeds 38.5°C
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Platform performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Joint Position Error Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of [68Ga]Ga-DOTA-TATE positive participants among CIM positive participants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of [68Ga]Ga-DOTA-TATE negative participants among CIM negative participants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in hepatic fat accumulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Feasibility of intratumoral DaRT seeds implantation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Safety of intratumoral DaRT seeds implantation
Endpoint domain: Adverse events/effects
Primary endpoint: Change in frequency of sorting/discarding behavior
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in duration of sorting/discarding behavior
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in score on the University of Rhode Island Change Assessment Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in score on the Apathy Evaluation Scale (AES-S)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Safety and effectiveness of Stream Platform operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lay users' satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Immune cell response measured by concentration of inflammatory molecules and proteins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rate of safety-relevant events per 100 miles/minutes ridden
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of safety behaviors per 100 miles/minutes ridden
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of positive and negative behaviors relative to the overall number of instances of a given event behavior
Endpoint domain: Adverse events/effects
Primary endpoint: Extension success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of follow up
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in dietary lapses
Endpoint domain: Life impact
Endpoint subdomain: Nutrition
Primary endpoint: Level of function in daily life
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: LT4 dose required to maintain TSH in target range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in electromyographic activity of temporalis and masseter muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change of symptoms of anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cardiorespiratory fitness (as % of predicted V̇O2max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants without clinically meaningful cerebral swelling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Significant increase in infarct volume from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Intervention-related serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of perforation
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of fistula formation
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of gastroesophageal reflux
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of stent migration
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of patients receiving technical successful stent placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Assessment of stress levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Ultrasound evaluation of volume status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Ultrasound evaluation of right heart function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Autonomous Motivation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Oxygen uptake at anaerobic threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of transitional and supportive care services (TSC) referrals
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Provider Satisfaction Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Identification of new biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Hospital mortality in patients who receive HFNC or invasive mechanical ventilation due to restrictions in care
Endpoint domain: Mortality/survival
Primary endpoint: change in depression scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of adverse events (CTCAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of adverse events (Bearman)
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum tolerated dose/recommended phase II dose (MTD/RP2D)
Endpoint domain: Adverse events/effects
Primary endpoint: Lipopolysaccharide binding protein (LBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: soluble CD14 (sCD14)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: neural responses to emotional scenes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: behavioral responses to emotional scenes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in mean variant allele frequency (VAF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Service engagement percentage
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Program acceptability rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: change of peak atrial longitudinal strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: change of peak atrial contraction strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: change of left atrial conduit strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Detection of AML Specific mutations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Safety and tolerability of VB-201
Endpoint domain: Adverse events/effects
Primary endpoint: Mean score related to knowledge about FGM
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of responders with active role in contrasting the procedures
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Proportion of responders feeling comfortable in treating patients affected
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: cosmetic improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Helkimo Index for Diagnosis of Temporomandibular Disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Questionnaire for Anamnestic Component of Helkimo Index
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinical Dysfunction Component of Helkimo Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: amount of dipping into retinal tissue with the ILM forceps during grasping
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance of digital speech assessment data
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Quality of digital speech assessment data
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Usability of digital speech assessments
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Child's BMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skin carotenoids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the actual chance to avoid new lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the bacterial count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in the salivary pH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the Plaque index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: islet β-cell function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Quality of life after intervention
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Neonatal glucose levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of participants with any adverse events (AEs) and serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with overall response (partial or better) as determined by IMWG criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neuropathic sensory phenotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Periodontal depth decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of using home monitoring devices
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Successful Acquisition of EGF Mapping and High Density Mapping
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with development of protein calorie malnutrition (PCM)
Endpoint domain: Adverse events/effects
Primary endpoint: ECG Tracing Quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cardiac Rhythm Determination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in hypertensive medication prescriptions or dosage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: COVID Ordinal Outcome Scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of participants with post-neonatal epilepsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Need for admission to ICU
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Type of intratumoral microbiota
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discharge criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Parental Attitude Scale Towards Rational Drug Use mean score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Plasma melatonin concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amplitude of waves
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Latency of waves
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes